Comment on Lent et al. All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes. Diabetes Care 2017;40:1379-1385.

The authors comment on a study published in a previous issue which reports on mortality in patients with and without diabetes undergoing gastric bypass or medical treatment. Topics covered include the benefit of gastric bypass versus medical treatment to patients with diabetes, long-term mortality with bariatric surgery in comparison with nonsurgical treatment, and the effectiveness of bariatric surgery in preventing mortality in patients with and without diabetes.